YBX1 and breast carcinoma: YBX-1 exhibits high expression levels in various tumors, including breast cancer, prostate cancer, osteosarcoma, lung cancer, colorectal cancer (CRC), glioblastoma, ovarian cancer (OC), GC, and melanoma.